Abstract
Tau protein concentrations were measured in the CSF of 23 patients with dementia of the Alzheimer type (DAT), 36 patients with multi-infarct dementia (MID), and 23 control subjects. Tau protein concentrations were significantly higher in patients with DAT than in controls (P < 0.001) and patients with MID (P < 0.001). A significantly positive correlation between CSF tau protein and glucose concentrations (r = 0.79, P < 0.001) and evolution of disease (r = 0.47, P < 0.05), and a negative correlation with Folstein's mental state examination test (r = -0.73, P < 0.001) were found in patients with DAT.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Adolfsson R., Bucht G., Lithner F., Winblad B. Hypoglycemia in Alzheimer's disease. Acta Med Scand. 1980;208(5):387–388. doi: 10.1111/j.0954-6820.1980.tb01217.x. [DOI] [PubMed] [Google Scholar]
- Arriagada P. V., Growdon J. H., Hedley-Whyte E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992 Mar;42(3 Pt 1):631–639. doi: 10.1212/wnl.42.3.631. [DOI] [PubMed] [Google Scholar]
- Bancher C., Braak H., Fischer P., Jellinger K. A. Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients. Neurosci Lett. 1993 Nov 12;162(1-2):179–182. doi: 10.1016/0304-3940(93)90590-h. [DOI] [PubMed] [Google Scholar]
- Beal M. F., Mazurek M. F., Black P. M., Martin J. B. Human cerebrospinal fluid somatostatin in neurologic disease. J Neurol Sci. 1985 Nov;71(1):91–104. doi: 10.1016/0022-510x(85)90039-5. [DOI] [PubMed] [Google Scholar]
- Beal M. F., Mazurek M. F., Chattha G. K., Svendsen C. N., Bird E. D., Martin J. B. Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease. Ann Neurol. 1986 Sep;20(3):282–288. doi: 10.1002/ana.410200303. [DOI] [PubMed] [Google Scholar]
- Davies P., Katzman R., Terry R. D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature. 1980 Nov 20;288(5788):279–280. doi: 10.1038/288279a0. [DOI] [PubMed] [Google Scholar]
- Degrell I., Hellsing K., Nagy E., Niklasson F. Amino acid concentrations in cerebrospinal fluid in presenile and senile dementia of Alzheimer type and multi-infarct dementia. Arch Gerontol Geriatr. 1989 Sep-Oct;9(2):123–135. doi: 10.1016/0167-4943(89)90033-2. [DOI] [PubMed] [Google Scholar]
- Ghanbari H. A., Kozuk T., Miller B. E., Riesing S. A sandwich enzyme immunoassay for detecting and measuring Alzheimer's disease--associated proteins in human brain tissue. J Clin Lab Anal. 1990;4(3):189–192. doi: 10.1002/jcla.1860040308. [DOI] [PubMed] [Google Scholar]
- Ghanbari H. A., Miller B. E., Haigler H. J., Arato M., Bissette G., Davies P., Nemeroff C. B., Perry E. K., Perry R., Ravid R. Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. JAMA. 1990 Jun 6;263(21):2907–2910. [PubMed] [Google Scholar]
- Hoyer S., Nitsch R. Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm. 1989;75(3):227–232. doi: 10.1007/BF01258634. [DOI] [PubMed] [Google Scholar]
- Khachaturian Z. S. Diagnosis of Alzheimer's disease. Arch Neurol. 1985 Nov;42(11):1097–1105. doi: 10.1001/archneur.1985.04060100083029. [DOI] [PubMed] [Google Scholar]
- Khatoon S., Grundke-Iqbal I., Iqbal K. Brain levels of microtubule-associated protein tau are elevated in Alzheimer's disease: a radioimmuno-slot-blot assay for nanograms of the protein. J Neurochem. 1992 Aug;59(2):750–753. doi: 10.1111/j.1471-4159.1992.tb09432.x. [DOI] [PubMed] [Google Scholar]
- Martinez M., Frank A., Hernanz A. Relationship of interleukin-1 beta and beta 2-microglobulin with neuropeptides in cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neuroimmunol. 1993 Nov-Dec;48(2):235–240. doi: 10.1016/0165-5728(93)90197-7. [DOI] [PubMed] [Google Scholar]
- Matus A. Microtubule-associated proteins: their potential role in determining neuronal morphology. Annu Rev Neurosci. 1988;11:29–44. doi: 10.1146/annurev.ne.11.030188.000333. [DOI] [PubMed] [Google Scholar]
- McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
- Mercken M., Vandermeeren M., Lübke U., Six J., Boons J., Vanmechelen E., Van de Voorde A., Gheuens J. Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection. J Neurochem. 1992 Feb;58(2):548–553. doi: 10.1111/j.1471-4159.1992.tb09754.x. [DOI] [PubMed] [Google Scholar]
- Miller D. C. Is it time to reassess the pathological criteria for a diagnosis of Alzheimer disease? Alzheimer Dis Assoc Disord. 1993 Fall;7(3):129–131. doi: 10.1097/00002093-199307030-00001. [DOI] [PubMed] [Google Scholar]
- Morris J. C., McKeel D. W., Jr, Storandt M., Rubin E. H., Price J. L., Grant E. A., Ball M. J., Berg L. Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging. Neurology. 1991 Apr;41(4):469–478. doi: 10.1212/wnl.41.4.469. [DOI] [PubMed] [Google Scholar]
- Morrison J. H., Rogers J., Scherr S., Benoit R., Bloom F. E. Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature. 1985 Mar 7;314(6006):90–92. doi: 10.1038/314090a0. [DOI] [PubMed] [Google Scholar]
- Mukaetova-Ladinska E. B., Harrington C. R., Roth M., Wischik C. M. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease. Am J Pathol. 1993 Aug;143(2):565–578. [PMC free article] [PubMed] [Google Scholar]
- Sakurada T., Alufuzoff I., Winblad B., Nordberg A. Substance P-like immunoreactivity, choline acetyltransferase activity and cholinergic muscarinic receptors in Alzheimer's disease and multi-infarct dementia. Brain Res. 1990 Jun 25;521(1-2):329–332. doi: 10.1016/0006-8993(90)91561-t. [DOI] [PubMed] [Google Scholar]
- Vandermeeren M., Mercken M., Vanmechelen E., Six J., van de Voorde A., Martin J. J., Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J Neurochem. 1993 Nov;61(5):1828–1834. doi: 10.1111/j.1471-4159.1993.tb09823.x. [DOI] [PubMed] [Google Scholar]
- Wilcock G. K., Esiri M. M. Plaques, tangles and dementia. A quantitative study. J Neurol Sci. 1982 Nov;56(2-3):343–356. doi: 10.1016/0022-510x(82)90155-1. [DOI] [PubMed] [Google Scholar]